PMC:7441788 / 16449-16953
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T101 | 363-371 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T177 | 95-97 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
| T178 | 421-422 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T210 | 56-58 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T211 | 59-64 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T212 | 82-84 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T213 | 108-110 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T214 | 153-155 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T215 | 248-253 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T216 | 292-297 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T217 | 331-333 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T131 | 56-58 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T132 | 82-84 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T133 | 108-110 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T134 | 153-155 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T135 | 331-333 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T103 | 363-371 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T123 | 0-17 | Sentence | denotes | Borba et al [49]. |
| T124 | 18-504 | Sentence | denotes | Randomized controlled trial High-dose CQ group: n = 40;Low-dose CQ group:n = 41 high-dose CQ (600 mg/2 times/day, for 10 day);low-dose CQ (450 mg/2 times/day for 5 days, double dose on 1st day) The mortality rate in the high-dose group was more than double that in low-dose group Double-blind study; 2 dosages of CQ for the first time in severe COVID-19 Small sample size; single-center design; Lack of a placebo control; Lack of exclusion criteria based on the QTc interval at baseline |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 659 | 56-58 | Chemical | denotes | CQ | MESH:D002738 |
| 660 | 82-84 | Chemical | denotes | CQ | MESH:D002738 |
| 661 | 108-110 | Chemical | denotes | CQ | MESH:D002738 |
| 662 | 153-155 | Chemical | denotes | CQ | MESH:D002738 |
| 663 | 331-333 | Chemical | denotes | CQ | MESH:D002738 |
| 706 | 216-225 | Disease | denotes | mortality | MESH:D003643 |
| 707 | 363-371 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T94 | 363-371 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 659 | 56-58 | Chemical | denotes | CQ | MESH:D002738 |
| 660 | 82-84 | Chemical | denotes | CQ | MESH:D002738 |
| 661 | 108-110 | Chemical | denotes | CQ | MESH:D002738 |
| 662 | 153-155 | Chemical | denotes | CQ | MESH:D002738 |
| 663 | 331-333 | Chemical | denotes | CQ | MESH:D002738 |
| 706 | 216-225 | Disease | denotes | mortality | MESH:D003643 |
| 707 | 363-371 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T123 | 0-17 | Sentence | denotes | Borba et al [49]. |
| T124 | 18-504 | Sentence | denotes | Randomized controlled trial High-dose CQ group: n = 40;Low-dose CQ group:n = 41 high-dose CQ (600 mg/2 times/day, for 10 day);low-dose CQ (450 mg/2 times/day for 5 days, double dose on 1st day) The mortality rate in the high-dose group was more than double that in low-dose group Double-blind study; 2 dosages of CQ for the first time in severe COVID-19 Small sample size; single-center design; Lack of a placebo control; Lack of exclusion criteria based on the QTc interval at baseline |